Personal importation
What FDA guidance does—and does not—mean
Enforcement discretion, evidence considerations, government authority, and common misconceptions.
FAQs and resources
Make the pathway understandable before making it personal.
Start with plain-language answers about prescriptions, personal importation, sourcing, cold-chain fulfillment, privacy, and employer programs.
Frequently asked questions
Answers for individuals.
The full maintained library will become canonical in LiveAgent after production configuration. These public answers remain intentionally general.
Who is the consumer pathway designed for?
The MVP is written for U.S. individuals exploring a patient-specific international access question. Case review does not guarantee that a medicine, source, or shipment is eligible.
Do I need a prescription?
A valid prescription and treating-clinician information may be required depending on the medicine and case. PharmaViaRx does not diagnose or prescribe.
What does FDA personal-importation guidance allow?
FDA says importing prescription drugs is illegal in most circumstances. Personnel may consider enforcement discretion in narrow situations based on the facts and evidence. This is not advance permission.
How are sources and products checked?
The intended model covers supplier authorization, license scope, product identity, batch, expiry, packaging, traceability, handling, and approved quality status. Named claims require evidence.
How are cold-chain shipments handled?
Requirements are product- and route-specific. Qualified packaging, route planning, monitoring, customs exposure, and excursion procedures must be supported by approved evidence.
What happens if customs delays or refuses a shipment?
Support can communicate status and coordinate approved next steps, but cannot direct or overturn FDA or CBP decisions. Timing, release, return, or disposition depend on the circumstances.
Can I send my prescription by email or chat?
No. Public email and general chat are not approved sensitive-data channels. Support will identify the approved secure route after production review.
Can PharmaViaRx guarantee savings?
No. Costs and potential savings are case-specific and depend on product, source, fees, exchange rates, handling, and outcome.
Resource library
Topics prepared for the LiveAgent Knowledge Base.
Article titles and full import-ready drafts are maintained in the repository content package for pharmacy, regulatory, quality, privacy, and legal review.
Case preparation
Preparing a patient-specific request
Information that may be required and where sensitive records should never be sent.
GLP-1 and cold-chain
Questions to ask before fulfillment
Identity, presentation, prescription, storage, route, monitoring, and receipt considerations.
Quality
How international sourcing checks work
Supplier qualification, licenses, product evidence, batch traceability, and quality agreements.
Delivery
When customs or a carrier delays a shipment
Status, authority, escalation, cold-chain risk, and possible case outcomes.
Employer programs
Evaluating specialty cost containment responsibly
Member experience, clinical independence, governance, quality, privacy, and validated economics.
Still have a question?